Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 54.26

-1.5%

10:51 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: quidditch who wrote (10712)	2/29/2004 3:15:50 PM
From: Michael Young	Read Replies (3) of 52153

I agree. SEPR has a chance to be the best "biopharma" growth story around with xop, Estorra, and the xop MDI. I didn't get back in after the Soltara debacle. Now I'm looking for a reasonable entry point. When will PFE file for indoplin? Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next